Replikins’ BioRadar(TM) Announced by UK Trade and Investment

Flu Pandemic Warning Company Sets Up in UK
LONDON, March 29, 2010 — UK Trade and Investment (http://www.newsroom.uktradeinvest.gov.uk/news.ashx) has announced the formation of BioRadar UK Limited. BioRadar is building on the recent success of Replikins’ genomic analysis of influen…

First H1N1 Swine Flu Vaccine, Replikins-Based, Is Ready Now for Testing Worldwide

LONDON, May 4, 2009 — A synthetic peptide H1N1 vaccine is available now for testing worldwide, from Replikins Ltd. The company has developed the vaccine based on the same Replikins peptide technology which provided the surprise advance warning one year ago that the current H1N1 outbreak/pandem…